Generali Investments CEE investicni spolecnost a.s. Purchases Shares of 500 Humana Inc. (NYSE:HUM)

Generali Investments CEE investicni spolecnost a.s. purchased a new stake in Humana Inc. (NYSE:HUM) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 500 shares of the insurance provider’s stock, valued at approximately $127,000.

Several other hedge funds also recently added to or reduced their stakes in the business. FPC Investment Advisory Inc. purchased a new stake in shares of Humana during the 4th quarter worth about $27,000. Centricity Wealth Management LLC purchased a new stake in shares of Humana during the 4th quarter worth about $30,000. Ashton Thomas Securities LLC purchased a new stake in shares of Humana during the 3rd quarter worth about $31,000. Atwood & Palmer Inc. boosted its stake in shares of Humana by 64.5% during the 4th quarter. Atwood & Palmer Inc. now owns 153 shares of the insurance provider’s stock worth $39,000 after acquiring an additional 60 shares in the last quarter. Finally, Kestra Investment Management LLC purchased a new stake in shares of Humana during the 4th quarter worth about $49,000. 92.38% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several equities research analysts have recently issued reports on the stock. Morgan Stanley lowered their target price on shares of Humana from $301.00 to $285.00 and set an “equal weight” rating on the stock in a research note on Wednesday, February 12th. Barclays increased their target price on shares of Humana from $255.00 to $270.00 and gave the stock an “equal weight” rating in a research note on Thursday, February 13th. Cantor Fitzgerald reissued a “neutral” rating and set a $290.00 target price on shares of Humana in a research note on Wednesday, February 12th. Royal Bank of Canada restated an “outperform” rating and set a $283.00 price target on shares of Humana in a research report on Wednesday, February 12th. Finally, Truist Financial upped their price target on shares of Humana from $260.00 to $290.00 and gave the stock a “hold” rating in a research report on Monday, January 6th. Twenty analysts have rated the stock with a hold rating and five have assigned a buy rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Hold” and an average target price of $285.68.

Humana Stock Down 2.2 %

HUM stock opened at $259.86 on Monday. The company has a market cap of $31.35 billion, a price-to-earnings ratio of 26.12, a PEG ratio of 2.05 and a beta of 0.57. The company has a current ratio of 1.76, a quick ratio of 1.76 and a debt-to-equity ratio of 0.68. Humana Inc. has a 12 month low of $213.31 and a 12 month high of $406.46. The firm has a 50-day moving average of $271.80 and a two-hundred day moving average of $283.10.

Humana (NYSE:HUM) last announced its quarterly earnings results on Tuesday, February 11th. The insurance provider reported ($2.16) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($2.26) by $0.10. Humana had a net margin of 1.02% and a return on equity of 11.70%. As a group, analysts forecast that Humana Inc. will post 16.47 earnings per share for the current fiscal year.

Humana Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, April 25th. Stockholders of record on Friday, March 28th will be issued a dividend of $0.885 per share. The ex-dividend date is Friday, March 28th. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.36%. Humana’s dividend payout ratio is currently 35.58%.

Insider Transactions at Humana

In other news, insider Timothy S. Huval sold 3,703 shares of the firm’s stock in a transaction that occurred on Tuesday, December 31st. The shares were sold at an average price of $256.26, for a total transaction of $948,930.78. Following the completion of the sale, the insider now owns 8,181 shares in the company, valued at $2,096,463.06. This trade represents a 31.16 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Insiders own 0.32% of the company’s stock.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.